Hibiotic tablets and suspension composition :
– tablet 375 mg, 625 mg. 1000 mg (1 gm):
Each film coated tablet contains amoxycillin (trihydrate) 250 mg, 500 mg or 875 mg in addition to clavulanic acid 125 mg as potassium salt
– Powder for oral suspension 230mg:
Each 5 ml after reconstitution contains amoxycillin (trihydrate) 200 mg in addition to clavulanic acid 30 mg as potassium salt
– Powder for oral suspension 460 mg:
Each 5 ml after reconstitution contains amoxycillin ((rihydrate) 400 mg in addition to clavulanic acid 60 mg as potassium salt.
– Powder for oral suspension 600 mg:
Each 5 ml after reconstitution contains amoxycillin (trihydrate) 600 mg in addition to clavulanic acid 42.9 mg as potassium salt.
Hibiotic tablets and suspension pharmacokinetic properties:
Amoxycillin and clavulanic acid are well absorbed from the gastrointestinal tract after oral administration and are not affected by food intake.
Approximatety 90% of amoxycilhn appears in blood. Amoxycillin diffuses readity into most body tissues and fluids.
Hibiotic tablets and suspension pharmacological properties :
Both Hibiotic@ tablets and Hibiotic N® suspension are antibacterial combination of amoxycillin and clavulanic acid as potassium salt. Amoxycillin is a semisynthetic penicillin with a broad spectrum bactericidal activity against several Gram positive and Gram negalive bacteria. Clavulanic acid generally acts as an irreversible, competitive Inhibitor of B-Iactamases. Therefore, the administration of clavulanic acid with amoxycillin results in a synergistic bactericidal effect which expands the spectrum of activity of amoxycillin.
Hibiotic® tablets and Hibiotic suspension are stable in the presence of gastric secretions and are well absorbed after oral administration.
Hibiotic tablets and suspension antibacterial activity :
Hibiotic® tablets and Hibiotic N® suspension are a potent bactericidal against a wide range of Gram positive and Gram negative bacteria, including IS-Iactamase producing organisms as well as different anaerobes:
– Aerobic Gram +ve & Gram-ve bacteria:
.Staphylococcal species • Streptococcal species • Haemophiluls influenzae
. Klebsiella species • Escherichia coli • Neisseria species
. Salmonella species • Moraxella catarrhalis • Shigella species
. Proteus mirabilis • Bordetella pertussis
– Anaerobic Gram +ve & Gram-ve bacteria:
. Clostridium species • Bacteroides fragilis • Peptococcus species
. Peptostreptococcus species
Hibiotic tablets and suspension indications :
– Acute or persistent or recurrent otitis media
– Upper respiratory tract infections, e.g.,acute or chronic sinusitis, recurrent tonsillits
– Lower respiratory tract infections, e.g., bronchitis, lobar and bronchopneumonia, lung abscess
– Skin and soft tissue infections e.g., abscesses, cellulitis, wound infections
– Genito=llrinaty tract infectlons e.g, stitis, urethritis
– Gynecological infections, e.g., pelvic infections, postpartum infections
– Dental infections, e.g., dental abscess
Hibiotic tablets and suspension dosage for oral administration:
Hibiotic® tablets and Hibiotic N® suspension are not affected by food, so it can be taken with or after meals. Adult & Children over 12 years:
Mild to moderate infections: One tablet 375 mg every 8 hours.
Severe infections: One tablet 1000 mg (1 gm) every 12 hours or one tablet 625 mg every 8 hours.
2 months-2 years: 2.5ml to 5ml HibioticN® 230 mg every 12 hours
2 – 6 years: 2.5ml to 5ml of Hibiotic N 460 mg every 12 hours
6- 12 years: 7.5ml to 10 ml of Hibiotic N 460 mg every 12 hours
For persistent and recurrent middle ear infections ( from 3 months and above)
use Hibiotic N 600mg suspension in a dose of 90 mg/kg/day divided in 2 equal doses every 12 hours
Treatment with Hibiotic® should not exceed 14 days
Dose should be adjusted in severe renal failure.
Preparation of Hibiotic N® suspension :
First shake the bottle to loosen the powder. Then add sterile water, shake well and fill up to the mark on the bottle.
Hibiotic tablets and suspension drug interactions:
Few drugs interactions may occur with Probencid and allopurinol.
As with other broad spectrum antibiotic, Hibiotic® may reduce the efficacy of oral contraceptives.
Hibiotic tablets and suspension use during pregnancy:
Both amoxyicillin and clavulanic acid are category B . Hibiotic® should not be used during pregnancy unless it is prescribed by the physician.
Hibiotic tablets and suspension use during lactation:
Although little amounts of Hibiotic® are excreted in milk, it could be used safely during lactation.
Hibiotic tablets and suspension adverse effects :
Uncommon and may include nausea, vomitine, abdominal discomfort or skin rash. Other side effects which are very rare include erythema multiforme, Stevens- Johnson Syndrome, erythematous rashes associated with glandular fever, exfoliative dermatitis, pseudomembranous colitis, hepatitis. and cholestatic jaundice which is usually reversible.
Hibiotic tablets and suspension Precautions :
During prolonged therapy with HibiotiC® renal, hepatic and hematologic functions should be evaluated.
Hibiotic tablets and suspension contraindications :
Hypersensitivity to penicillins and/or clavulanic acid.
How Supplied :
Hibiotic 1000 mg (1 gm) Tablet: Strips of 8 film coated tablets in packs of 1 or 2 strips.
Hibiotic® 625 mg Tablet: Strips of 10 film coated tablets in packs of 1 strip.
Hibiotic® 375 mg Tablet: Strips of 10 film coated tablets in packs of 1 strip.
Hibiotic N® 600 mg Powder for oral suspension: Bottles of 80 ml after reconstitution with sterile water.
Hibiotic N® 460 mg Powder for oral suspension: Bottles of 60 ml after reconstitution with sterile water.
Hibiotic N® 230 mg Powder for oral suspension: Bottles of 60 ml after reconstitution with sterile water.
Keep all medicaments out of reach of children
AMOUN PHARMACEUTICAL CO. SAE.
EJ-Obour City, Cairo, Egypt.